{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:48:00Z","timestamp":1764812880466,"version":"3.41.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Quantitative Systems Pharmacology (QSP) is a drug discovery approach that integrates computational and experimental methods in an iterative way to gain a comprehensive, unbiased understanding of disease processes to inform effective therapeutic strategies. We report the implementation of QSP to Huntington\u2019s Disease, with the application of a chemogenomics platform to identify strategies to protect neuronal cells from mutant huntingtin induced death. Using the ST<jats:italic>Hdh<\/jats:italic><jats:sup><jats:italic>Q111<\/jats:italic><\/jats:sup>cell model, we investigated the protective effects of small molecule probes having diverse canonical modes-of-action to infer pathways of neuronal cell protection connected to drug mechanism. Several mechanistically diverse protective probes were identified, most of which showed less than 50% efficacy. Specific combinations of these probes were synergistic in enhancing efficacy. Computational analysis of these probes revealed a convergence of pathways indicating activation of PKA. Analysis of phospho-PKA levels showed lower cytoplasmic levels in ST<jats:italic>Hdh<\/jats:italic><jats:sup><jats:italic>Q111<\/jats:italic><\/jats:sup>cells compared to wild type ST<jats:italic>Hdh<\/jats:italic><jats:sup><jats:italic>Q7<\/jats:italic><\/jats:sup>cells, and these levels were increased by several of the protective compounds. Pharmacological inhibition of PKA activity reduced protection supporting the hypothesis that protection may be working, in part, through activation of the PKA network. The systems-level studies described here can be broadly applied to any discovery strategy involving small molecule modulation of disease phenotype.<\/jats:p>","DOI":"10.1038\/s41598-017-17378-y","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T11:33:07Z","timestamp":1513164787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington\u2019s Disease Model through the Application of Quantitative Systems Pharmacology"],"prefix":"10.1038","volume":"7","author":[{"given":"Fen","family":"Pei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Titus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat Can","family":"Cobanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed H.","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongying","family":"Shun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prema","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Carlisle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-4176","authenticated-orcid":false,"given":"Ivet","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Lansing","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Lezon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Schurdak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"17378_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato, C., Valenza, M. & Cattaneo, E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiological reviews 90, 905\u2013981, https:\/\/doi.org\/10.1152\/physrev.00041.2009 (2010).","journal-title":"Physiological reviews"},{"key":"17378_CR2","first-page":"217","volume":"86","author":"EB Clabough","year":"2013","unstructured":"Clabough, E. B. Huntington\u2019s disease: the past, present, and future search for disease modifiers. Yale J Biol Med 86, 217\u2013233 (2013).","journal-title":"Yale J Biol Med"},{"key":"17378_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona, V. O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease. Nature 399, 263\u2013267 (1999).","journal-title":"Nature"},{"key":"17378_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen, M. et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6, 797\u2013801, https:\/\/doi.org\/10.1038\/77528 (2000).","journal-title":"Nat Med"},{"key":"17378_CR5","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1073\/pnas.1832501100","volume":"100","author":"X Wang","year":"2003","unstructured":"Wang, X. et al. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease. Proceedings of the National Academy of Sciences 100, 10483\u201310487, https:\/\/doi.org\/10.1073\/pnas.1832501100 (2003).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"17378_CR6","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1523\/JNEUROSCI.1867-08.2008","volume":"28","author":"X Wang","year":"2008","unstructured":"Wang, X. et al. Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington\u2019s Disease. Journal of Neuroscience 28, 9473\u20139485, https:\/\/doi.org\/10.1523\/jneurosci.1867-08.2008 (2008).","journal-title":"Journal of Neuroscience"},{"key":"17378_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nn.3721","volume":"17","author":"H Yano","year":"2014","unstructured":"Yano, H. et al. Inhibition of mitochondrial protein import by mutant huntingtin. Nature neuroscience 17, 822\u2013831, https:\/\/doi.org\/10.1038\/nn.3721 (2014).","journal-title":"Nature neuroscience"},{"key":"17378_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/2472555216682725","volume":"22","author":"A Gough","year":"2017","unstructured":"Gough, A. et al. Biologically Relevant Heterogeneity: Metrics and Practical Insights. SLAS discovery 22, 213\u2013237, https:\/\/doi.org\/10.1177\/2472555216682725 (2017).","journal-title":"SLAS discovery"},{"key":"17378_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2013.09.001","volume":"155","author":"A Chakravarti","year":"2013","unstructured":"Chakravarti, A., Clark, A. G. & Mootha, V. K. Distilling Pathophysiology from Complex Disease Genetics. Cell 155, 21\u201326, https:\/\/doi.org\/10.1016\/j.cell.2013.09.001 (2013).","journal-title":"Cell"},{"key":"17378_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/1087057116635818","volume":"21","author":"AM Stern","year":"2016","unstructured":"Stern, A. M., Schurdak, M. E., Bahar, I., Berg, J. M. & Taylor, D. L. A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine. J Biomol Screen 21, 521\u2013534, https:\/\/doi.org\/10.1177\/1087057116635818 (2016).","journal-title":"J Biomol Screen"},{"key":"17378_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1517\/17460441.2015.1082543","volume":"10","author":"VI Perez-Nueno","year":"2015","unstructured":"Perez-Nueno, V. I. Using quantitative systems pharmacology for novel drug discovery. Expert opinion on drug discovery 10, 1315\u20131331, https:\/\/doi.org\/10.1517\/17460441.2015.1082543 (2015).","journal-title":"Expert opinion on drug discovery"},{"key":"17378_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.chembiol.2015.11.008","volume":"23","author":"BK Wagner","year":"2016","unstructured":"Wagner, B. K. & Schreiber, S. L. The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods. Cell chemical biology 23, 3\u20139, https:\/\/doi.org\/10.1016\/j.chembiol.2015.11.008 (2016).","journal-title":"Cell chemical biology"},{"key":"17378_CR13","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel, F. Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Human Molecular Genetics 9, 2799\u20132809, https:\/\/doi.org\/10.1093\/hmg\/9.19.2799 (2000).","journal-title":"Human Molecular Genetics"},{"key":"17378_CR14","doi-asserted-by":"publisher","first-page":"e102678","DOI":"10.1371\/journal.pone.0102678","volume":"9","author":"AH Gough","year":"2014","unstructured":"Gough, A. H. et al. Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery. PloS one 9, e102678, https:\/\/doi.org\/10.1371\/journal.pone.0102678 (2014).","journal-title":"PloS one"},{"key":"17378_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nn.3367","volume":"16","author":"B Lu","year":"2013","unstructured":"Lu, B. et al. Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance. Nature neuroscience 16, 562\u2013570, https:\/\/doi.org\/10.1038\/nn.3367 (2013).","journal-title":"Nature neuroscience"},{"key":"17378_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2008.150","volume":"16","author":"G Kroemer","year":"2009","unstructured":"Kroemer, G. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell death and differentiation 16, 3\u201311, https:\/\/doi.org\/10.1038\/cdd.2008.150 (2009).","journal-title":"Cell death and differentiation"},{"key":"17378_CR17","doi-asserted-by":"publisher","first-page":"80ps16","DOI":"10.1126\/scitranslmed.3001862","volume":"3","author":"R Huang","year":"2011","unstructured":"Huang, R. et al. The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med 3, 80ps16, https:\/\/doi.org\/10.1126\/scitranslmed.3001862 (2011).","journal-title":"Sci Transl Med"},{"key":"17378_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","volume":"47","author":"WR Greco","year":"1995","unstructured":"Greco, W. R., Bravo, G. & Parsons, J. C. The search for synergy: a critical review from a response surface perspective. Pharmacological reviews 47, 331\u2013385 (1995).","journal-title":"Pharmacological reviews"},{"key":"17378_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"C Bliss","year":"1939","unstructured":"Bliss, C. The toxicity of poisons applied jointly. Ann Appl Biol 26, 585\u2013615 (1939).","journal-title":"Ann Appl Biol"},{"key":"17378_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou, T. C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in enzyme regulation 22, 27\u201355 (1984).","journal-title":"Advances in enzyme regulation"},{"key":"17378_CR21","unstructured":"ChEMBL- Isoetarine, https:\/\/www.ebi.ac.uk\/chembl\/bioactivity\/results (2016)."},{"key":"17378_CR22","unstructured":"ChEMBL - Benztropine, https:\/\/www.ebi.ac.uk\/chembl\/bioactivity\/results (2016)."},{"key":"17378_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1345\/aph.18003","volume":"33","author":"JA Barone","year":"1999","unstructured":"Barone, J. A. Domperidone: a peripherally acting dopamine2-receptor antagonist. The Annals of pharmacotherapy 33, 429\u2013440 (1999).","journal-title":"The Annals of pharmacotherapy"},{"key":"17378_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0024-3205(71)90086-5","volume":"10","author":"G Poch","year":"1971","unstructured":"Poch, G. & Kukovetz, W. R. Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues. Life sciences. Pt. 1: Physiology and pharmacology 10, 133\u2013144 (1971).","journal-title":"Life sciences. Pt. 1: Physiology and pharmacology"},{"key":"17378_CR25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/MCB.01434-12","volume":"33","author":"JT Lin","year":"2013","unstructured":"Lin, J. T. et al. Regulation of feedback between protein kinase A and the proteasome system worsens Huntington\u2019s disease. Molecular and cellular biology 33, 1073\u20131084, https:\/\/doi.org\/10.1128\/MCB.01434-12 (2013).","journal-title":"Molecular and cellular biology"},{"key":"17378_CR26","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1016\/S0021-9258(19)34116-X","volume":"265","author":"T Chijiwa","year":"1990","unstructured":"Chijiwa, T. et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. The Journal of biological chemistry 265, 5267\u20135272 (1990).","journal-title":"The Journal of biological chemistry"},{"key":"17378_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. The Biochemical journal 351, 95\u2013105 (2000).","journal-title":"The Biochemical journal"},{"key":"17378_CR28","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.122re4","volume":"1","author":"AJ Murray","year":"2008","unstructured":"Murray, A. J. Pharmacological PKA inhibition: all may not be what it seems. Science signaling 1, re4, https:\/\/doi.org\/10.1126\/scisignal.122re4 (2008).","journal-title":"Science signaling"},{"key":"17378_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"CT Supuran","year":"2003","unstructured":"Supuran, C. T., Scozzafava, A. & Casini, A. Carbonic anhydrase inhibitors. Medicinal research reviews 23, 146\u2013189, https:\/\/doi.org\/10.1002\/med.10025 (2003).","journal-title":"Medicinal research reviews"},{"key":"17378_CR30","doi-asserted-by":"publisher","first-page":"ra121","DOI":"10.1126\/scisignal.aaa1877","volume":"7","author":"CA Martz","year":"2014","unstructured":"Martz, C. A. et al. Systematic identification of signaling pathways with potential to confer anticancer drug resistance. Sci Signal 7, ra121, https:\/\/doi.org\/10.1126\/scisignal.aaa1877 (2014).","journal-title":"Sci Signal"},{"key":"17378_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nchembio.1308","volume":"9","author":"AS Tsvetkov","year":"2013","unstructured":"Tsvetkov, A. S. et al. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nature Chemical Biology 9, 586\u2013592, https:\/\/doi.org\/10.1038\/nchembio.1308 (2013).","journal-title":"Nature Chemical Biology"},{"key":"17378_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm.4011","volume":"22","author":"N Myeku","year":"2016","unstructured":"Myeku, N. et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat Med 22, 46\u201353, https:\/\/doi.org\/10.1038\/nm.4011 (2016).","journal-title":"Nat Med"},{"key":"17378_CR33","doi-asserted-by":"publisher","first-page":"16513","DOI":"10.1073\/pnas.0405973101","volume":"101","author":"LM DiPilato","year":"2004","unstructured":"DiPilato, L. M., Cheng, X. & Zhang, J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proceedings of the National Academy of Sciences of the United States of America 101, 16513\u201316518, https:\/\/doi.org\/10.1073\/pnas.0405973101 (2004).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"17378_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nchembio.799","volume":"8","author":"V Sample","year":"2012","unstructured":"Sample, V. et al. Regulation of nuclear PKA revealed by spatiotemporal manipulation of cyclic AMP. Nat Chem Biol 8, 375\u2013382, https:\/\/doi.org\/10.1038\/nchembio.799 (2012).","journal-title":"Nat Chem Biol"},{"key":"17378_CR35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bbrc.2006.07.136","volume":"348","author":"MD Allen","year":"2006","unstructured":"Allen, M. D. & Zhang, J. Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochemical and biophysical research communications 348, 716\u2013721, https:\/\/doi.org\/10.1016\/j.bbrc.2006.07.136 (2006).","journal-title":"Biochemical and biophysical research communications"},{"key":"17378_CR36","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1016\/j.febslet.2005.03.089","volume":"579","author":"GS Baillie","year":"2005","unstructured":"Baillie, G. S., Scott, J. D. & Houslay, M. D. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS letters 579, 3264\u20133270, https:\/\/doi.org\/10.1016\/j.febslet.2005.03.089 (2005).","journal-title":"FEBS letters"},{"key":"17378_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2015.00177","volume":"6","author":"L Rinaldi","year":"2015","unstructured":"Rinaldi, L., Sepe, M., Donne, R. D. & Feliciello, A. A dynamic interface between ubiquitylation and cAMP signaling. Front Pharmacol 6, 177, https:\/\/doi.org\/10.3389\/fphar.2015.00177 (2015).","journal-title":"Front Pharmacol"},{"key":"17378_CR38","doi-asserted-by":"crossref","first-page":"13377","DOI":"10.1016\/S0021-9258(18)98850-2","volume":"266","author":"DI Morris","year":"1991","unstructured":"Morris, D. I., Robbins, J. D., Ruoho, A. E., Sutkowski, E. M. & Seamon, K. B. Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter. The Journal of biological chemistry 266, 13377\u201313384 (1991).","journal-title":"The Journal of biological chemistry"},{"key":"17378_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drudis.2012.11.008","volume":"18","author":"DB Kell","year":"2013","unstructured":"Kell, D. B., Dobson, P. D., Bilsland, E. & Oliver, S. G. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug discovery today 18, 218\u2013239, https:\/\/doi.org\/10.1016\/j.drudis.2012.11.008 (2013).","journal-title":"Drug discovery today"},{"key":"17378_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.1199","volume":"9","author":"M Schenone","year":"2013","unstructured":"Schenone, M., Dancik, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 9, 232\u2013240, https:\/\/doi.org\/10.1038\/nchembio.1199 (2013).","journal-title":"Nat Chem Biol"},{"key":"17378_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nchembio.216","volume":"5","author":"U Rix","year":"2009","unstructured":"Rix, U. & Superti-Furga, G. Target profiling of small molecules by chemical proteomics. Nat Chem Biol 5, 616\u2013624, https:\/\/doi.org\/10.1038\/nchembio.216 (2009).","journal-title":"Nat Chem Biol"},{"key":"17378_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1039\/C6NP00001K","volume":"33","author":"MH Wright","year":"2016","unstructured":"Wright, M. H. & Sieber, S. A. Chemical proteomics approaches for identifying the cellular targets of natural products. Natural product reports 33, 681\u2013708, https:\/\/doi.org\/10.1039\/c6np00001k (2016).","journal-title":"Natural product reports"},{"key":"17378_CR43","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1609122","author":"D Pamies","year":"2016","unstructured":"Pamies, D. et al. A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity. Altex. https:\/\/doi.org\/10.14573\/altex.1609122 (2016).","journal-title":"Altex"},{"key":"17378_CR44","unstructured":"Rosen, D. S. et al. Pesticidal Cyanine Dye Derivatives (2003)."},{"key":"17378_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymeth.2015.10.007","volume":"96","author":"A Gough","year":"2016","unstructured":"Gough, A., Shun, T. Y., Taylor, D. L. & Schurdak, M. A metric and workflow for quality control in the analysis of heterogeneity in phenotypic profiles and screens. Methods 96, 12\u201326, https:\/\/doi.org\/10.1016\/j.ymeth.2015.10.007 (2016).","journal-title":"Methods"},{"key":"17378_CR46","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.0604348103","volume":"103","author":"J Inglese","year":"2006","unstructured":"Inglese, J. et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proceedings of the National Academy of Sciences of the United States of America 103, 11473\u201311478, https:\/\/doi.org\/10.1073\/pnas.0604348103 (2006).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"17378_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","volume":"115","author":"TC Chou","year":"1981","unstructured":"Chou, T. C. & Talalay, P. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. European journal of biochemistry \/ FEBS 115, 207\u2013216 (1981).","journal-title":"European journal of biochemistry \/ FEBS"},{"key":"17378_CR48","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1021\/ci400219z","volume":"53","author":"MC Cobanoglu","year":"2013","unstructured":"Cobanoglu, M. C., Liu, C., Hu, F., Oltvai, Z. N. & Bahar, I. Predicting drug-target interactions using probabilistic matrix factorization. Journal of chemical information and modeling 53, 3399\u20133409, https:\/\/doi.org\/10.1021\/ci400219z (2013).","journal-title":"Journal of chemical information and modeling"},{"key":"17378_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/bioinformatics\/btu599","volume":"31","author":"MC Cobanoglu","year":"2015","unstructured":"Cobanoglu, M. C., Oltvai, Z. N., Taylor, D. L. & Bahar, I. BalestraWeb: efficient online evaluation of drug-target interactions. Bioinformatics 31, 131\u2013133, https:\/\/doi.org\/10.1093\/bioinformatics\/btu599 (2015).","journal-title":"Bioinformatics"},{"key":"17378_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PC Hawkins","year":"2007","unstructured":"Hawkins, P. C., Skillman, A. G. & Nicholls, A. Comparison of shape-matching and docking as virtual screening tools. Journal of medicinal chemistry 50, 74\u201382 (2007).","journal-title":"Journal of medicinal chemistry"},{"key":"17378_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/1087057114521867","volume":"19","author":"W Zhao","year":"2014","unstructured":"Zhao, W. et al. A New Bliss Independence Model to Analyze Drug Combination Data. J Biomol Screen 19, 817\u2013821, https:\/\/doi.org\/10.1177\/1087057114521867 (2014).","journal-title":"J Biomol Screen"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17378-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T18:48:03Z","timestamp":1751136483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17378-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17378"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17378-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"13 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17803"}}